News
Micron Technology, Inc. (NASDAQ:MU) is one of the best large-cap stocks to buy right now. On June 26, Baird increased its ...
A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" ...
Shares of Performance Food Group climbed after Bloomberg reported that U.S. Foods has been evaluating an acquisition of the food distribution company. The stock gained 7.6%, to $97.27, in premarket ...
Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...
In the latest close session, Pfizer (PFE) was up +1.51% at $25.62. The stock's performance was ahead of the S&P 500's daily loss of 0.07%. Elsewhere, the Dow saw a downswing of 0.37%, while the ...
WCM Investment Management increased its Pfizer holdings by 8.7% in Q1, snagging an extra 10,051 shares worth $3.17 million.
Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...
12d
Zacks Investment Research on MSNHere is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending StockPfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
15d
TipRanks on MSNPfizer’s Bold Clinical Trials Could Boost Stock PerformancePfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is actively advancing its ...
Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average analyst price target is $29.17, despite recent coverage showing a cautious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results